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The Other Breast: Indications for Biopsy and/or Mastectomy! 
Charles S. Rogers, MD" 
A search for malignant and premalignant lesions in 162 
contralateral biopsy and/or mastectomy specimens 
yielded 45 (27.8%,) malignancies and 54 (33%) premalig-
nant lesions (atypical epithelial hyperplasia, Wel lings 
grades III and IV). In those with no palpable or mammo-
graphic suspicion of malignancy, the cancer incidence 
was 73.8%. Eight malignancies occurred one month to 
three years after antecedent biopsies which revealed 
premalignant lesions. No cancer has been detected after 
biopsies which revealed hyperplasia of grade II or less. 
Cancer size at time of discovery varied significantly with 
the method of detection: average 2.7 cm by palpation; 
1.6 cm by mammography; 0.5 cm by biopsy. Axillary 
metastasis was present in 30%, 20%, and 70%, respec-
tively. Axillary metastasis from occult contralateral cancer 
occurred in three instances where none was found from 
ipsilateral, clinically evident cancers; synchronous in 
two; asynchronous in one by eight years. In a subgroup 
ofone hundred prophylactic biopsies performed by the 
author, patients with Wolfe P2-DY patterns (vs. N1-P1) 
had a high incidence of malignancy (20%, vs. 72.5%) and 
af a younger age (average; 53 vs. 73 years). Routine 
contralateral biopsy synchronous with ipsilateral mas-
tectomy is recommended. Patients with contralateral 
severe epithelial atypia should have the option of pro-
phylactic mastectomy. 
Breast cancer is frequently a multicentric and bilateral 
disease. Clinically, these characteristics may be absent or 
obscure but readily apparent to those who study serial 
sections of whole breast specimens (1-3). A segmental 
resection may remove only a small part of the disease, 
and even a radical mastectomy leaves 50% of the target 
tissue at risk. If, like the thyro id , the breast(s) had a small 
strip of tissue between the two lobes, it would be consi-
dered one organ rather than two. 
Malignancy begins at the same t ime or asynchronously 
in mult iple terminal ductal lobular units (TDLU) and 
evolves f rom epithelial hyperplasia, to anaplasia, to in 
situ carcinoma, and finally to invasive malignancy (1). 
The t ime interval f rom hyperplasia to in situ malignancy 
is unknown, but studies of growth rates indicate that 
invasive breast cancers, on the average, double in 
volume in one hundred days (4-5). At this growth rate, it 
takes six to eight years for one cancer cell to become one 
bi l l ion cells in a mass 1.0 cm in diameter, but only 
another three hundred days before it grows to eight 
bi l l ion cells in a 2.0 cm mass. 
Despite this long latency per iod, we are able to detect 
less than 10% of breast cancers while they are still smaller 
than l .Ocmand less than 3% whi le they are still noninva-
sive (6). The short interval required for a cancer to dou-
ble in size explains, in part, why so many " in terva l " 
cancers are detected by patients between annual physi-
cal and/or mammographic examinations. Except for 
data f rom the Breast Cancer Detection Demonstration 
Projects (BCDDP), scant evidence exists that we are 
detecting breast cancer earlier (7). Unti l we discover 
better early detection methods, most women who 
develop breast cancer wi l l eventually die f rom it (8). A 
reduction in mortality may require a more aggressive 
use of biopsies in those at known high risk. We need to 
know if, and how often, this aggressive approach would 
detect lesions significantly earlier—and if the benefits 
exceed the risk. Addit ional ly, we need to know how 
often, and under what circumstances, epithelial atypia 
proceeds to invasive malignancy. One such clue may be 
the demonstration that some epithelial hyperplasias can 
stimulate neovascularity (5). 
This communicat ion reports an analysis of 162 consecu-
tive biopsies and/or mastectomies in a group of 450 
patients who had known cancer in one breast. 
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Materials and Methods 
We analyzed 162 consecutive contralateral biopsies 
and/or mastectomies (in a group of 450 patients at risk) 
at Bay Medical Center between January 1977 through 
August 1982. Indications fo r the procedures varied with 
the individual surgeon and with t ime. Specimen size 
varied f rom minimal biopsies to the entire breast. Most 
biopsies consisted of a ful l thickness segment of breast 
tissue, about one half of a quadrant, or the subareolar 
segment. In the absence of palpable abnormalities, the 
location of prominent ducts, dysplasias, and asymme-
tries indicated by mammograms was used to determine 
where to perform the biopsy. 
Two physicians, instructed in Wolfe's system of classifi-
cation of mammographic patterns (9), interpreted the 
mammograms. When elements of both P2 and DV 
existed, the pattern was usually classified as P2. Only a 
few prominent ducts resulted in a PI rather than N l 
classification. 
Epithelial hyperplasias were graded by the method of 
Wellings (1). Thoroughness of histopathologic study of 
specimens varied with the individual pathologist and 
with t ime. During the course of the study. Dr. Thomas 
Cajigas and associates, with the aid of Dr. Wellings, devel-
oped a rapid, subgross method of studying serial sec-
tions of breast specimens (unpublished), which increased 
the incidence of premalignant, in situ, and microinva-
sive lesions. 
Results 
Forty-five of 162 (27.8%) contralateral biopsies or mas-
tectomies resulted in a diagnosis of malignancy: 33 were 
invasive; 12 in situ. Fifty-three patients (33%) had prema-
lignant lesions or atypical epithelial hyperplasia (Wel-
lings grade III [27] or IV [26]). A cancer incidence of 
13.6% was found in those with no palpable or mammo-
graphic suspicion of malignancy. This f inding is consist-
ent with the studies reported by Urban and Leis (10). 
The size of the cancer and incidence of axillary lymph 
node metastasis varied significantly with the method of 
detection (Table I). Only 20% of the 20 palpable cancers 
were less than 2.0 cm in diameter, and 30% had axillary 
metastasis. The five nonpalpable cancers detected by 
mammography were earlier cancers and illustrate the 
value of mammographic surveillance. Twenty of the 45 
cancers, however, were discovered by biopsy in patients 
with no palpable or mammographic evidence of malig-
nancy. Of these 20 cancers, 70% were 0.5 cm or less in 
diameter, and only two had axillary metastasis. Three 
patients with pathological stage I ipsilateral cancers had 
axillary metastasis from occult cancers in the contralat-
eral breast: synchronous in two cases and asynchronous 
(eight years) in one case. 
During this study, one in situ and seven invasive cancers 
have been discovered fol lowing 61 antecedent biopsies 
that revealed moderate or severe epithelial atypia. Thus 
far, no contralateral malignancy has been detected in 
patients in whom the highest grade of epithelial hyper-
plasia in a biopsy specimen was Wellings grade II or less. 
This is consistent wi th evidence that severe epithelial 
atypia in abnormal terminal ductal lobular units is, 
indeed, preneoplastic (1,2). 
In a series of one hundred consecutive prophylactic 
biopsies performed by the author as a subgroup in this 
study, patients with prominent ducts (Wolfe P2 pattern) 
or generalized coalescent dysplasia (Wolfe DY) had a 
higher incidence of contralateral invasive cancers and 
severe epithelial hyperplasia than those with N1-P1 pat-
terns (Table II). These results are consistent wi th those of 
Wellings and Wolfe (9), who reported that xeroradio-
graphic and histological risk grades correlate closely. In 
biopsies of breasts without malignancy, the highest 
grades of precancerous epithelial abnormality were 
found in those with P2 and DV patterns, seldom in PI , 
and rarely in those with N l patterns (10). 
In patients whose biopsies had Wolfe P2-DY patterns, 
detection of the first cancer occurred at an average age 
of 49 years, and the second at age 53.1 n those with N l -PI 
patterns, the corresponding ages were 61 and 73. The 
reason for this age discrepancy remains unclear, although 
it is tempting to speculate that the breasts containing 
TABLE I 
Contralateral Breast Biopsies 
M e t h o d of Detect ion Correlated w i th 
Cancer Size and Lymph Node Metastasis 
Cancer Size 
Detect ion No. % wi th Average 2.0 cm 0.5 cm 
Me thod nod est o r < o r < 
Palpation 20 30% 2.7 cm 25% 5% 
Radiography 5 20 1.6 8C 20 
Biopsy 20t 10 0.5 85 70 
TOTALS 45* 20% 1.6 cm 58% 38% 
*33 invasive and 12 in situ cancers 
tA l l 20 nonpalpable and not visible on mammography 
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prominent ducts and severe dysplasias have been sub-
jected to more virulent and/or greater quantities of car-
cinogen(s). Patients with a family history of breast cancer 
had cancer at an earlier age than the entire group but no 
younger than those with P2-DY patterns. 
An attempt to correlate cancer bilaterality wi th mult i -
focal lesions in the first breast failed because of marked 
variance among pathologists in searching for additional 
lesions. The incidence ranged from 6% to 58%. The latter 
f igure is more consistent wi th the incidence recently 
reported by Egan (3). Attempts to correlate multicentric-
ity with the Wolfe patterns failed for thesame reason. No 
attempt was made to correlatethe incidence of bilateral-
ity wi th the histological grade or type of the tumor in the 
first cancer, nor with the presence or absence of estro-
gen receptors in the first cancer. 
Discussion 
Many investigators (1-3), including Samhouri, Block, and 
Kambouris (10), have documented the multicentric and 
bilateral nature of breast cancer. Urban and Leis (11) 
have demonstrated that significant numbers of occult 
contralateral breast cancers can be detected by routine 
contralateral biopsies, and greater numbers by selective 
contralateral prophylactic mastectomies. The incidence 
of bilaterality is higher than reported in those studies 
when cancers evident by palpation or mammography 
are included. Our study and others (10) indicate that the 
incidence varies with the method(s) of detection. It also 
varies with the size of the specimen, dil igence of the 
pathologist, and length of fo l low-up (9). 
If epithelial atypia is present in biopsy specimens, the 
patient is at a significantly higher risk of developing 
invasive cancer (12-14). In this study, eight patients with 
these lesions in antecedent biopsy specimens devel-
oped malignancies within three years after the biopsy 
was performed. Thus far, none of the patients with 
epithelial hyperplasia, Wellings grade II or less, have 
developed contralateral cancer. These data support the 
pathological evidence that severe atypical epithelial 
hyperplasia in abnormal terminal ductal lobular units is 
premalignant (1,2). It also supports the clinical studies of 
others indicating that patients with atypical epithelial 
hyperplasia are at considerably higher risk than those 
wi thout hyperplasia (12-14). The method of grading used 
in this study is similar to that of Black (13). It indicates 
whether cellular abnormalities of mammary epithel ium 
are mi ld , moderate, or severe. In the author's view, it is 
somewhat analogous in both method and significance to 
TABLE II 
Prophylactic Contralateral Breast Biopsy 
Correlated wi th Wol fe Patterns 











IV 111 l l o r < 
12.5% 2 1 % 54% 
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the classification of dysplasias of the uterus and cervix 
made by means of the Pap smear. It is helpful in making 
decisions about the management of the disease. 
Patients who have had cancer of one breast require 
constant surveillance. There is scant evidence, however, 
that such a procedure actually results in discovering the 
second cancer any earlier than the first one. Most 
patients in our study had not practiced routine self 
breast examination (SBE). In those with palpable cancers, 
the patients rarely had yearly mammograms. However, 
all twenty of the patients with cancer detected only by 
biopsy had had "negat ive" mammograms within one 
year before biopsy. There seems little doubt that SBE, 
frequent physical examinations, and screening mam-
mography can discover more cancers and at an earlier 
stage. If the patient and physician remain unconcerned, 
however, the result too often yields an incurable cancer 
in the contralateral breast. Contralateral biopsy at the 
t ime of the mastectomy requires only a small amount of 
additional effort, t ime, and cost; it results in little, if any, 
additional morbidity and no mortality. It allows detec-
t ion of some additional cancers and premalignant lesions 
and provides worthwhi le information which may well 
influence decisions about management of the disease. 
In our insti tut ion, 65-70% of the patients with prevalent 
cancers have P2 or DY mammographic patterns. Over 
90% of our false negative mammographic diagnoses also 
occur in these patterns. Patients wi th these patterns are 
also more diff icult to evaluate by palpation. In this study, 
they were found to have a higher risk of invasive contra-
lateral cancer or premalignant lesions. In the absence of 
palpable abnormalities, the locations of prominent ducts 
and areas of asymmetry aided considerably in choosing 
where to perform the biopsy. In patients who had no 
palpable abnormalities but diffuse symmetrical promi-
nent ducts or dysplasia, the biopsy was performed in 
mirror image locations, or the upper outer quadrant. 
In all breast cancer patients except in those with a known 
short life expectancy, valuable information can be pro-
vided by mammography, knowledgeable interpretation 
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of the Wolfe parenchymal patterns, contralateral biopsy, 
and a diligent search for premalignant and obscure 
malignant lesions by an informed and interested pathol-
ogist. These procedures all are needed to make logical 
decisions about therapy and surveillance. Serial section-
ing of the specimen and rapid subgross preparation (or 
radiography) of the slices helps considerably in identify-
ing significant lesions. The presence of severe atypical 
epithelial hyperplasia in terminal ductal lobular units 
puts the patient at a high risk of subsequent invasive 
cancer. In such patients, prophylactic mastectomy with 
reconstruction seems a logical alternative to constant 
surveillance. 
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